Aryl hydrocarbon receptor control of a disease tolerance defence pathway - Wikidata - awgldk - TriplyDB

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

http://www.wikidata.org/entity/Q33901562

about

Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms How the Innate Immune System Senses Trouble and Causes Trouble AhR-Mediated, Non-Genomic Modulation of IDO1 Function The Aryl Hydrocarbon Receptor: A Key Bridging Molecule of External and Internal Chemical Signals The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids Gene Expression Differences in Prostate Cancers between Young and Old Men Acute and chronic plasma metabolomic and liver transcriptomic stress effects in a mouse model with features of post-traumatic stress disorder Immunological Relevance of the Coevolution of IDO1 and AHR Loss of HIF-1α in macrophages attenuates AhR/ARNT-mediated tumorigenesis in a PAH-driven tumor model Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more.The Proteasome Inhibitor Bortezomib Controls Indoleamine 2,3-Dioxygenase 1 Breakdown and Restores Immune Regulation in Autoimmune Diabetes.Meat and Nicotinamide: A Causal Role in Human Evolution, History, and Demographics.Dynamic regulation of serum aryl hydrocarbon receptor agonists in MS Tryptophan metabolite activation of the aryl hydrocarbon receptor regulates IL-10 receptor expression on intestinal epithelia Tryptophan-catabolizing enzymes - party of three The cross-talk between opportunistic fungi and the mammalian host via microbiota's metabolism.Role of disease-associated tolerance in infectious superspreaders The lung metastatic niche.Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis.The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.A Structural Switch between Agonist and Antagonist Bound Conformations for a Ligand-Optimized Model of the Human Aryl Hydrocarbon Receptor Ligand Binding Domain Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.Tryptophan-degrading enzymes in tumoral immune resistance.Small-molecule control of cytokine function: new opportunities for treating immune disorders Autophagy mediates tolerance to Staphylococcus aureus alpha-toxin.Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.Gut feelings of safety: tolerance to the microbiota mediated by innate immune receptors.NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis.B Cell-Intrinsic IDO1 Regulates Humoral Immunity to T Cell-Independent Antigens.Full Spectrum of LPS Activation in Alveolar Macrophages of Healthy Volunteers by Whole Transcriptomic Profiling.Aryl Hydrocarbon Receptor Protects Lungs from Cockroach Allergen-Induced Inflammation by Modulating Mesenchymal Stem Cells.Aryl hydrocarbon receptor: Linking environment to immunity.Immunomodulation and Disease Tolerance to Staphylococcus aureus Bacterial Stimulation of Toll-Like Receptor 4 Drives Macrophages To Hemophagocytose.3,3'-Diindolylmethane Inhibits Flt3L/GM-CSF-induced-bone Marrow-derived CD103(+) Dendritic Cell Differentiation Regulating Phosphorylation of STAT3 and STAT5.AHR Function in Lymphocytes: Emerging Concepts

P2860

Q26765777-C1B47118-6916-439D-9732-D12325A68D65 Q26797214-DA4CE094-51DE-48FC-B3BA-FC590E8CD416 Q26800052-F26B3934-3ACE-442F-89BC-4B6EEFC4971D Q27016140-F3CA1C93-D988-4E37-A62A-3DA0404CF084 Q27693336-F79C0D7D-7E8A-40EA-AE4E-975422E662D8 Q28083139-4D0CEF2B-C4CD-4C1F-8B52-1D5448F0697F Q28275608-00632BB1-112D-4DB4-8F36-88063B3CFEC6 Q28389473-D81A8B73-598E-4E3B-B5CD-11FE13D9C50C Q28468529-9A28828B-CE2B-43E8-B8AC-1AF010102A2E Q28543119-61FAC05E-5164-48C8-AD91-E3CE0170B340 Q28654567-B9D8B3A0-97BF-4699-B294-BE330CED4E79 Q28828484-205F9944-D72D-4AF6-BD8D-BED32F277C52 Q30234910-BA40DAF3-7690-4146-B8FD-ABCB24FC85D8 Q33559343-A95672B6-9BF4-415A-8A73-64A3792A31E0 Q33637828-AACFE6B8-170B-4223-AA49-EF292463BF1A Q33808285-BE971762-9E6E-41BB-8EA7-4A6CBC5B7BDB Q33915720-732AAA83-CCE9-4987-BA0D-423ABFC58B37 Q34313731-C2BA3C8A-8F09-4922-885E-4039321525C0 Q34448291-CDA8022A-CE3A-41CE-8448-769C629B2A7F Q34480636-DEA306F7-5E21-4B85-A51B-598434CEF9E6 Q34498908-F8897E39-D00B-4DDF-AF2D-E760488AFE80 Q34508486-E8886484-4DF8-4C6E-B97E-4C5891CFC034 Q34553267-C47CA017-A793-42CA-AFB9-DD307F67BCA6 Q34792371-3FC355AB-ED6E-4324-8C5F-766C2F9B74B1 Q34913785-22428FBE-B054-44F7-8CB6-A35599C34C46 Q35042385-99B6D674-B40A-472D-8E37-E81072B777FD Q35252669-021610ED-349D-4AB3-A07A-E531D27F4B55 Q35356667-AF68FDF1-2896-4E2A-A8B4-CEC8CC5C4A71 Q35604318-C7CEEA7C-53B7-4D5B-B458-774EC3E5B691 Q35755201-F6E5ABF8-683A-4713-90EE-34F393183E3E Q35805959-0F50D717-BED3-4667-93AE-99961F47D2BA Q35935473-739AC23E-DFC8-4C64-87ED-BD07E4B25E67 Q35988832-3B81B15B-1CB4-4645-9A1F-CB1E852CD778 Q36081845-10CCA14C-6048-4F3E-BA32-E0620885B5A6 Q36349594-E6FC6A1E-724A-4773-B4E3-2AB62014D2F3 Q36378234-43978903-2DD0-4E8E-8993-F433F38305E0 Q36409380-553E1259-447E-486F-859B-980875DC9504 Q36410913-FDF1C2B0-237A-47A2-B468-467E2189FD7D Q36427732-8DA2037B-271B-4B2E-934A-5A78AE742858 Q36447796-A18D47DD-DE69-440E-BD26-EF3EB1CEDB41

P2860

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

http://www.wikidata.org/entity/Q33901562

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@ast

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@en

type

label

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@ast

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@en

prefLabel

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@ast

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@en

P1433

Q33901562-50DDFEB2-16FA-4543-98BB-D0B56A3CBBA2

P1476

Q33901562-C729158D-6C9F-4934-A09D-52E804BFBC33

P2093

Q33901562-126AA0FE-1668-466C-9753-24652E00BD9D

Q33901562-1E5000E4-16DF-45C5-9D97-A4692E1F8C7C

Q33901562-237EC3A6-1CAE-47AA-8935-197B94A21C8C

Q33901562-2FC30672-03EF-4EF8-AEEC-67F61FF8F752

Q33901562-4A08C35F-A26F-477C-AC12-3ECFA73D25F7

Q33901562-52CB4B63-8B7A-46A0-B2C0-8A6E5E7123CB

Q33901562-636AD4FC-2B71-44BB-A250-A3400453564F

Q33901562-63E581AB-7A9E-4405-A234-186871513294

Q33901562-77737023-3C03-46EB-BECB-930B752A7383

Q33901562-82AD7FD6-0B7D-4743-818E-AEE3612F3E5E

P2860

Q33901562-0011C829-12DE-4BFF-BDA4-60B23D304F3C

Q33901562-09205124-8BF4-4944-B3B9-7E384A19E2DB

Q33901562-10F4391B-3CDD-485E-854F-3E3CAD2BD15F

Q33901562-16FAF6BF-74EA-4B56-994C-83647D9F8BA1

Q33901562-18C8C1A7-4B57-4467-97F8-1090FDDE6C24

Q33901562-19C0B4E8-E189-4AB5-88A6-0D2F0F5B3DC9

Q33901562-1DA8782D-3DDA-4EEF-8C26-4D115FA97C94

Q33901562-1F9BADF9-C008-442F-A0C1-3E50C1864C65

Q33901562-20502FA7-49E4-4FC8-924B-C0A86E752B5A

Q33901562-23C3CA41-B18E-4ABB-890F-F4662A5775A8

P2888

Q33901562-E2C95FC8-C186-4044-80EE-A7A4FD69F0BC

P304

Q33901562-244676D4-226D-44A1-BEB1-75CDE2AA7DC9

P31

Q33901562-048F550F-EA2E-4031-A751-D68A4EB99B37

P356

Q33901562-ABBAE92F-E801-481C-886A-B1CB18F181BB

P407

Q33901562-82B0D6A7-74DF-436D-AAE7-FC7B900BC20E

P433

Q33901562-9F780553-5B24-4C9E-A3CB-F097713539B6

P478

Q33901562-CEBE5F54-A537-472B-8D93-679EBB6C2C23

P50

Q33901562-1BFCE03A-71AD-43C1-8E8C-BF3CBE9EB436

Q33901562-28805208-6D04-4ADA-BDB3-05AB96A11D98

Q33901562-2E15E67F-07D6-4163-A25D-9FBF454263B8

Q33901562-2E88D31B-D102-453D-B0D8-219D0EF2C808

Q33901562-30F41DC9-5E08-44F5-A54B-316F39D54BC4

Q33901562-4451D4F2-754E-49B3-8074-ED28FB58F61C

Q33901562-5D9B1BD9-7C43-48BA-97DC-9A76559D0A62

Q33901562-73BE4982-2522-4B6A-906A-CA01DA68445A

Q33901562-748F0E78-CEF2-41B1-8B47-2C9B47B16145

Q33901562-7D8906D2-65F2-4343-9952-ECC99105E5DD

P577

Q33901562-1D54EFA9-D997-4DCC-B80C-8DD274F02AB1

P5875

Q33901562-A81EFCD6-E588-475D-B73D-B27C236CFCF1

P698

Q33901562-4188FCF8-CFE1-44C0-A7F4-3E51DBF96B73

P932

Q33901562-E67C21B5-E26A-4A2E-BB52-312289BC8B6B

P356

P1433

P1476

Aryl hydrocarbon receptor control of a disease tolerance defence pathway

@en

P2093

Alban Bessede

http://www.w3.org/2001/XMLSchema#string

Bernard Veyret

http://www.w3.org/2001/XMLSchema#string

Cinzia Brunacci

http://www.w3.org/2001/XMLSchema#string

Danilo Piobbico

http://www.w3.org/2001/XMLSchema#string

David Gilot

http://www.w3.org/2001/XMLSchema#string

Emilia M C Mazza

http://www.w3.org/2001/XMLSchema#string

George C Prendergast

http://www.w3.org/2001/XMLSchema#string

Hiroshi Funakoshi

http://www.w3.org/2001/XMLSchema#string

James B DuHadaway

http://www.w3.org/2001/XMLSchema#string

Louis Boon

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of allogeneic fetal rejection by tryptophan catabolism

Disease tolerance as a defense strategy

The aryl hydrocarbon receptor: a molecular pathway for the environmental control of the immune response

Ligand binding and activation of the Ah receptor

An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor

Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism

IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses

Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock

Hexachlorobenzene triggers AhR translocation to the nucleus, c-Src activation and EGFR transactivation in rat liver

Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

P2888

P304

184-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE13323

http://www.w3.org/2001/XMLSchema#string

P407

P433

7508

http://www.w3.org/2001/XMLSchema#string

P478

511

http://www.w3.org/2001/XMLSchema#string

P50

Gilles J. Guillemin

Michael Platten

Francesca Fallarino

Silvio Bicciato

Giuseppe Servillo

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264633148

http://www.w3.org/2001/XMLSchema#string

P698

24930766

http://www.w3.org/2001/XMLSchema#string

P932

4098076

http://www.w3.org/2001/XMLSchema#string